gracecast-084_lung-cancer_alk inhibition: science and early clinical experience by dr. ben solomon
Published 12 years ago • 1.9K plays • Length 17:30Download video MP4
Download video MP3
Similar videos
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
12:46
gracecast-086_lung-cancer_q&a with drs. solomon and camidge on alk inhibition for advanced nsclc
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
2:15
new alk inhibitor drugs vs xalkori (crizotinib) for alk lung cancer patients
-
1:47
alk rearrangements: what are they, and who has them?
-
4:19
clinical trial spotlight: alchemist for early-stage alk and egfr lung cancer patients
-
9:59
case based panel discussions - alk positive, developing resistance to alk inhibitors and next steps
-
4:58
how do the new alk inhibitor drugs compare to xalkori (crizotinib) for alk lung cancer patients?
-
13:00
stage 3a node-positive lung adenocarcinoma with alk rearrangement - case based panel discussions
-
9:19
gracecast-004_lung-cancer_antiangiogenesis in first line nsclc
-
3:06
2020 ttf alk session qa panel progression on 2nd-gen alk inhibitor if biopsy shows no alk mutation
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
4:27
alk positive lung cancer forum: xalkori
-
7:41
gracecast - lcvl - h. jack west md - can alk inhibitors treat and prevent brain metastases
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
14:52
gracecast-031_lung-cancer_treatment - past, present, and future
-
10:06
gracecast-019_lung-cancer_cancer lifeline lecture part 1 sclc
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session